EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+17.74%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$3.94B
AUM Growth
+$3.94B
(+2.3%)
Cap. Flow
-$137M
Cap. Flow
% of AUM
-3.48%
Top 10 Holdings %
Top 10 Hldgs %
61.38%
Holding
66
New
15
Increased
8
Reduced
4
Closed
9
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$141M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
$100M |
| 3 |
CRISPR Therapeutics
CRSP
|
$94.7M |
| 4 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
$76.5M |
| 5 |
ADAP
Adaptimmune Therapeutics
ADAP
|
$43.3M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$435M |
| 2 |
argenx
ARGX
|
$115M |
| 3 |
Edgewise Therapeutics
EWTX
|
$40.9M |
| 4 |
Spyre Therapeutics
SYRE
|
$19.1M |
| 5 |
Revolution Medicines
RVMD
|
$3.8M |
Sector Composition
| 1 | Healthcare | 99.87% |
